SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — History and Physical — Billie Holiday

PatientBillie Holiday
Date of birth1993-04-07
IdentifiersMRN HR-ML010-SYN; SSN (made up) 000-10-4472
Document date2026-04-20
AuthorConstance Mayfield, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

Establishing primary care five weeks after release from custody: medication for opioid use disorder, overdose prevention, alcohol care, liver and infection screening, and depression and safety screening [S]

History of Present Illness

This fictional modern episode addresses the presenting concerns below. [S]

Historical basis. These claims are historical evidence, not findings from a modern examination.

3 later historical claims are omitted because they describe events after the index age. See the teaching note.

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
about 1943Heroin use from the early 1940s, becoming a severe addiction in the late 1940s; sought treatment for it at least onceD (CLM-0003, CLM-0005)
October 1945Heavier drinking and increased drug use after her mother's deathD (CLM-0002)
March 16, 1948Federal custody after a narcotics possession conviction, about ten months with enforced abstinence; released earlyD (CLM-0004)

Family History

RelativeConditionAge at deathEvidence
motherDied in 1945; cause not recorded in the cited sourceD (CLM-0002)

Social History

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Buprenorphine 8 mg and naloxone 2 mg sublingual film: half a film (4 mg) on day 1, then one film (8 mg) under the tongue dailyOne film under the tongue daily after a 4 mg first doseSublingual route2026-04-20 to 2026-04-27completedS
Naloxone 4 mg nasal spray, one spray in one nostril for a suspected opioid overdose; may repeat every 2 to 3 minutes in alternating nostrils; call 911One spray (4 mg) in one nostril for suspected overdose; repeat every 2 to 3 minutes if there is no responseNasal route2026-04-20activeS
Thiamine 100 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2026-04-20 to 2026-10-19completedS

Review of Systems

Positive for the concerns in the history of present illness. Alert, guarded at first and then candid; speech normal; no signs of intoxication or withdrawal. Mood low and tired, with grief for her mother that still returns; PHQ-9 score 9 with item 9 scored 0; no thoughts of suicide or self-harm. No other systems reported as affected in this synthetic episode. [S]

General Status

Alert and engaged. Independent in all activities; performing several nights a week; sleep broken since release. [S]

Physical Exam

Vital signs recorded on 2026-04-20; see the Vital Signs section. Mental status: Alert, guarded at first and then candid; speech normal; no signs of intoxication or withdrawal; Mood low and tired, with grief for her mother that still returns; PHQ-9 score 9 with item 9 scored 0; no thoughts of suicide or self-harm. The physical examination is limited to the findings relevant to this synthetic episode. [S]

Structured safety assessment: current ideation absent, intent absent, plan absent, access to means reviewed: yes. Outpatient care. Overdose risk is high in the weeks after release because tolerance has fallen: naloxone for her and her friend, never using alone, testing any drug supply with fentanyl test strips, and buprenorphine started today. The 988 Suicide & Crisis Lifeline was given and saved in her phone, and a written safety plan was made with her. Safety reviewed at every visit. [S]

Vital Signs

DateMeasureValueUnitProvenance
2026-04-20Body height165cmS
2026-04-20Body weight68kgS
2026-04-20Body mass index (BMI) [Ratio]25kg/m2S
2026-04-20Systolic blood pressure126mm[Hg]S
2026-04-20Diastolic blood pressure80mm[Hg]S
2026-04-20Heart rate84/minS
2026-04-20Respiratory rate16/minS
2026-04-20Body temperature36.8CelS
2026-04-20Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-04-20Hemoglobin [Mass/volume] in Blood12.4g/dL11.6-15 g/dLNormalS
2026-04-20MCV [Entitic mean volume] in Red Blood Cells by Automated count101fL80-100 fLHighS
2026-04-20Platelets [#/volume] in Blood by Automated count23610*3/uL150-400 10*3/uLNormalS
2026-04-20Sodium [Moles/volume] in Serum or Plasma138mmol/L135-145 mmol/LNormalS
2026-04-20Potassium [Moles/volume] in Serum or Plasma4mmol/L3.5-5.1 mmol/LNormalS
2026-04-20Creatinine [Mass/volume] in Serum or Plasma0.72mg/dL0.59-1.04 mg/dLNormalS
2026-04-20Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M113mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-04-20Glucose [Mass/volume] in Serum or Plasma88mg/dL70-99 mg/dLNormalS
2026-04-20Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma52U/L10-40 U/LHighS
2026-04-20Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma38U/L7-56 U/LNormalS
2026-04-20Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma84U/L5-40 U/LHighS
2026-04-20Albumin [Mass/volume] in Serum or Plasma4g/dL3.5-5 g/dLNormalS
2026-04-20Bilirubin.total [Mass/volume] in Serum or Plasma0.7mg/dL0.1-1.2 mg/dLNormalS
2026-04-20Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay0.09{s_co_ratio}Below 1.00 is nonreactiveNormalS
2026-04-20Hepatitis B virus surface Ab [Units/volume] in Serum3m[IU]/mL>=10 m[IU]/mLLowS
2026-04-20Phosphatidylethanol [Mass/volume] in Blood312ng/mLBelow 20 ng/mL: abstinence or light drinking; 20 to 199: significant drinking; 200 or more: heavy drinkingHighS
2026-04-20Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]9{score}S
2026-04-20Total score [AUDIT-C]8{score}S
2026-04-20Total score [DAST-10]7{score}S

Problems

ProblemClinical statusVerificationCodeProvenance
Opioid use disorder (heroin), severe; in early remission in a controlled environment at intake, five weeks after release from custody; on buprenorphine; synthetic modern episode linked to her documented heroin useactiveconfirmed F11.20S — Synthetic modern coding of the documented heroin addiction; language is person-first, and the code does not change with a return to use.
Alcohol use disorder, moderate; synthetic modern episode linked to her documented heavier drinking after her mother's deathactiveconfirmed F10.20S — Synthetic modern coding of the documented drinking; the liver disease reported in her last year is not coded, because it was documented long after the episode.

Assessment

Plan of Treatment